- Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrenceGassa Asmae; Fassunke Jana; Schuetten Sarah; Kuhlmann Luca; Scherer Marie; Sun Jie; Zhao Yue; Michel Max; Loeser Heike; Wolf Juergen; Buettner Reinhard; Doerr Fabian; Heldwein Matthias; Hagmeyer Lars; Frank Konrad; Merkelbach Bruse Sabine; Quaas Alexander; Bruns Christiane J.; Alakus HakanLung Cancer, 2020, prepublish.
- Detecting driver mutations by AmoyDx 11-gene PCR with high concordance with next-generation sequencing in Chinese non-small cell lung cancer patientsLin, D.; Xi, Y.; Meng, H.; Feng, Q.; Lian, S.; Gao, N.; Guo, J.; Yang, X.; Deng, S.; Li, M.; Gai, F.; Zhu, C.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- Analysis of MET genetic aberrations in Chinese solid tumor patients.Huang, Guanglong; Bian, Zhengying; Ma, Juan; Chen, Siqi; Lu, Guanghua; Ding, Ran; Bu, FanfengAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 1
会议论文
Droplet digital PCR as an alternative method for detecting MET amplification in patients with non-small cell lung cancer.
15阅读
